Siste oppdatering :
19/11/2024
Infostab
Lister
Sammendrag
Søk etter kompatibilitet
Y-side kompatibilitetstabell
Referanser
Forskerteamet
valistab
plakat
Tilkoblinger
sponsorer
Forfatter
Instruksjon
Nyhetsbrev
Referanser 199
Type :
Journal
Forskerteamet :
Baltimore - University of Maryland, School of Pharmacy
Forfattere :
Hassan E, Leslie J, Martir-Herrero ML.
Tittel :
Stability of labetalol hydrochloride with selected critical care drugs during simulated Y-site injection.
Nummer :
Am J Hosp Pharm ; 51: 2143-2145. 1994
Nivå of Evidence :
fysisk stabilitet :
kjemisk stabilitet :
andre metoder :
Kommentarer :
Lister
Dobutamine hydrochloride
2.5 mg/ml
+
Labetalol hydrochloride
1 mg/ml
+
Dopamine hydrochloride
1.6 mg/ml
+
Labetalol hydrochloride
1 mg/ml
+
Labetalol hydrochloride
1 mg/ml
+
Dobutamine hydrochloride
2.5 mg/ml
+
1 mg/ml
+
Dopamine hydrochloride
1.6 mg/ml
+
1 mg/ml
+
Morphine sulfate
0.5 mg/ml
+
1 mg/ml
+
Nitroglycerin
0.2 mg/ml
+
1 mg/ml
+
Ranitidine hydrochloride
0.6 mg/ml
+
Morphine sulfate
0.5 mg/ml
+
Labetalol hydrochloride
1 mg/ml
+
Nitroglycerin
0.2 mg/ml
+
Labetalol hydrochloride
1 mg/ml
+
Ranitidine hydrochloride
0.6 mg/ml
+
Labetalol hydrochloride
1 mg/ml
+
20°C-25°C
Labetalol hydrochloride
1 mg/ml
Dobutamine hydrochloride
2,5 mg/ml
4
20°C-25°C
Labetalol hydrochloride
1 mg/ml
Dopamine hydrochloride
1,6 mg/ml
4
20°C-25°C
Labetalol hydrochloride
1 mg/ml
Morphine sulfate
0,5 mg/ml
4
20°C-25°C
Labetalol hydrochloride
1 mg/ml
Nitroglycerin
0,2 mg/ml
4
20°C-25°C
Labetalol hydrochloride
1 mg/ml
Ranitidine hydrochloride
0,6 mg/ml
4
Mentions Légales
